Azzimonti, Matteo
Margoni, Monica
Zanetta, Chiara
Genovese, Federica
Martinelli, Vittorio
Rocca, Maria A.
Baldoli, Cristina
Moiola, Lucia
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 20 November 2023
Revised: 18 December 2023
Accepted: 18 December 2023
First Online: 28 December 2023
Declarations
:
: M. Azzimonti received travel grants from Novartis. M. Margoni reports grants and personal fees from Almiral. She was awarded a MAGNIMS-ECTRIMS fellowship in 2020. C. Zanetta received compensation for speaking activities, and/or consulting services from Alexion, Biogen, Merck, Novartis, Roche, Sanofi. F. Genovese has nothing to disclose. V. Martinelli received compensation for speaking and/or for consultancy and support for travel expenses and participation in Congresses from Biogen, Merck-Serono, Novartis, Genzyme and TEVA Pharmaceutical Industries. M.A. Rocca received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche; and speaker honoraria from AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. She is Associate Editor for <i>Multiple Sclerosis and Related Disorders</i>.. C. Baldoli has nothing to disclose. L. Moiola received compensation for speaking activities, and/or consulting servicesfrom Merck, Biogen, Novartis, Roche, Sanofi, and TEVA. M. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, <i>Neurological Sciences,</i> and <i>Radiology</i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
: The Ethics Committee of San Raffaele Scientific Institute waived the need for ethics approval for publication of case reports.
: Written informed consent was obtained from patients for the usage of clinical data in anonymized fashion.
: Written informed consent was obtained from patients to publish their anonymized data and clinical history.